JP2018501215A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501215A5 JP2018501215A5 JP2017529357A JP2017529357A JP2018501215A5 JP 2018501215 A5 JP2018501215 A5 JP 2018501215A5 JP 2017529357 A JP2017529357 A JP 2017529357A JP 2017529357 A JP2017529357 A JP 2017529357A JP 2018501215 A5 JP2018501215 A5 JP 2018501215A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- salt according
- salt
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462086844P | 2014-12-03 | 2014-12-03 | |
| US62/086,844 | 2014-12-03 | ||
| PCT/IB2015/058965 WO2016087975A1 (en) | 2014-12-03 | 2015-11-19 | Cd38 inhibitors and methods of treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018501215A JP2018501215A (ja) | 2018-01-18 |
| JP2018501215A5 true JP2018501215A5 (enExample) | 2018-11-01 |
| JP6550132B2 JP6550132B2 (ja) | 2019-07-24 |
Family
ID=54708091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017529357A Active JP6550132B2 (ja) | 2014-12-03 | 2015-11-19 | Ｃｄ３８阻害剤及び治療の方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9840496B2 (enExample) |
| EP (1) | EP3227275B1 (enExample) |
| JP (1) | JP6550132B2 (enExample) |
| KR (1) | KR20170090478A (enExample) |
| CN (1) | CN107428733A (enExample) |
| AU (1) | AU2015356721B2 (enExample) |
| BR (1) | BR112017011642A2 (enExample) |
| CA (1) | CA2969178A1 (enExample) |
| ES (1) | ES2717260T3 (enExample) |
| RU (1) | RU2017121002A (enExample) |
| WO (1) | WO2016087975A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3544612A4 (en) | 2016-11-23 | 2020-05-13 | Acetylon Pharmaceuticals, Inc. | PHARMACEUTICAL COMBINATIONS COMPRISING A HISTONE DEACETYLASE INHIBITOR AND A CD38 INHIBITOR AND METHODS OF USING THE SAME |
| WO2020146795A1 (en) | 2019-01-11 | 2020-07-16 | Omeros Corporation | Methods and compositions for treating cancer |
| US11535621B2 (en) * | 2019-07-31 | 2022-12-27 | Ribon Therapeutics, Inc. | Heterobicyclic amides as inhibitors of CD38 |
| US20230025807A1 (en) * | 2019-10-30 | 2023-01-26 | Mitobridge Inc. | Cd38 inhibitors |
| KR20230051425A (ko) * | 2020-04-07 | 2023-04-18 | 미토브리지, 인크. | Cd38 억제제 |
| IL301991A (en) * | 2020-10-09 | 2023-06-01 | Napa Therapeutics Ltd | Heteroaryl amide inhibitors for CD38 |
| EP4263524A1 (en) | 2020-12-21 | 2023-10-25 | Cytokinetics, Inc. | Pyrazole derivatives useful as nampt modulators |
| AR124718A1 (es) | 2021-01-29 | 2023-04-26 | Ribon Therapeutics Inc | Quinolinas y azaquinolinas como inhibidores de cd38 |
| EP4288053A4 (en) | 2021-02-08 | 2024-12-18 | Ohio State Innovation Foundation | Small molecule inhibitors of cd38 as immunosuppressants |
| CN117715897A (zh) * | 2021-04-30 | 2024-03-15 | 南京艾美斐生物医药科技有限公司 | 化合物及其作为cd38抑制剂的用途 |
| US20230116972A1 (en) * | 2021-07-12 | 2023-04-20 | Cytokinetics, Inc. | Cd38 modulators and methods of use thereof |
| EP4724430A1 (en) * | 2023-06-07 | 2026-04-15 | Flagship Pioneering Innovations VI, LLC | Condensed azines as inhibitors of cyclic adp ribose hydrolase |
| WO2026000074A1 (en) * | 2024-06-25 | 2026-01-02 | Welnx Company Inc. | Use of cd38 inhibitors for reducing th2 inflammation |
| WO2026075971A1 (en) | 2024-10-01 | 2026-04-09 | Neolaia Inc. | Combination therapy for treatment of metabolic disorders and inflamation related disorders using incretin compounds and cd38 inhibitors |
| WO2026090190A1 (en) * | 2024-10-22 | 2026-04-30 | Aeovian Pharmaceuticals, Inc. | Cd38 modulators and uses thereof |
| CN119775288B (zh) * | 2024-12-31 | 2025-10-10 | 浙江工业大学 | 一种cd38抑制化合物及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1370139A4 (en) * | 2001-01-04 | 2010-09-22 | Einstein Coll Med | INHIBITORS OF ADP-RIBOSYLTRANSFERASES, CYCLASES AND HYDROLASES AND THEIR USE |
| US7022680B2 (en) * | 2002-05-30 | 2006-04-04 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases |
| WO2010025235A1 (en) * | 2008-08-29 | 2010-03-04 | Regents Of The University Of Michigan | Selective ligands for the dopamine 3 (d3) receptor and methods of using the same |
| EP2801573A1 (en) * | 2013-05-09 | 2014-11-12 | Sanofi | Hydantoine derivatives as CD38 inhibitors |
-
2015
- 2015-11-19 CN CN201580073761.2A patent/CN107428733A/zh active Pending
- 2015-11-19 ES ES15801951T patent/ES2717260T3/es active Active
- 2015-11-19 AU AU2015356721A patent/AU2015356721B2/en not_active Ceased
- 2015-11-19 KR KR1020177018180A patent/KR20170090478A/ko not_active Withdrawn
- 2015-11-19 WO PCT/IB2015/058965 patent/WO2016087975A1/en not_active Ceased
- 2015-11-19 CA CA2969178A patent/CA2969178A1/en not_active Abandoned
- 2015-11-19 EP EP15801951.3A patent/EP3227275B1/en active Active
- 2015-11-19 US US15/529,120 patent/US9840496B2/en active Active
- 2015-11-19 BR BR112017011642A patent/BR112017011642A2/pt not_active Application Discontinuation
- 2015-11-19 JP JP2017529357A patent/JP6550132B2/ja active Active
- 2015-11-19 RU RU2017121002A patent/RU2017121002A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006378B (en) | N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof | |
| JP2017514910A5 (enExample) | ||
| AR105238A1 (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso | |
| JP2013032389A5 (enExample) | ||
| JP2015537020A5 (enExample) | ||
| RU2017121002A (ru) | Ингибиторы CD38 и способы лечения | |
| MX373436B (es) | Compuesto peptidico. | |
| JP2016505637A5 (enExample) | ||
| EP3954679A3 (en) | Amide compounds for the treatment of hiv infections | |
| MX377916B (es) | Compuestos 4-amino-imidazoquinolina. | |
| JP2016528301A5 (enExample) | ||
| JP2017501237A5 (enExample) | ||
| NZ729005A (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| JP2018521020A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| EA201790389A1 (ru) | Пирролопиримидиновые соединения, используемые в качестве агониста tlr7 | |
| JP2016518437A5 (enExample) | ||
| MX2015001571A (es) | Compuestos de anillo en puente como inhibidores del virus de la hepatitis c (hcv) y sus aplicaciones farmaceuticas. | |
| JP2015516427A5 (enExample) | ||
| JP2015536325A5 (enExample) | ||
| RU2018113718A (ru) | Новые соединения | |
| EP4599830A3 (en) | Isoxazoline compounds for use in treating demodicosis | |
| EA201691150A1 (ru) | Соединения изопропилтриазолопиридина | |
| JP2016529315A5 (enExample) | ||
| JP2015521195A5 (enExample) |